A clinical trial of AX-158 in atopic dermatitis.
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs AX 158 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- 24 Jan 2025 New trial record
- 22 Jan 2025 According to Artax Biopharma media release, company planning a study in atopic dermatitis patients with clinical results anticipated by the end of 2026.